Bruce R. Zetter
#128,158
Most Influential Person Now
Bruce R. Zetter's AcademicInfluence.com Rankings
Bruce R. Zetterphilosophy Degrees
Philosophy
#6099
World Rank
#9072
Historical Rank
Logic
#3290
World Rank
#4423
Historical Rank
Bruce R. Zetterbiology Degrees
Biology
#8257
World Rank
#11304
Historical Rank
Biochemistry
#1184
World Rank
#1303
Historical Rank
Download Badge
Philosophy Biology
Why Is Bruce R. Zetter Influential?
(Suggest an Edit or Addition)Bruce R. Zetter's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein (1984) (1237)
- Angiogenesis and tumor metastasis. (1998) (1000)
- Long-term culture of capillary endothelial cells. (1979) (750)
- Tumor interactions with the vasculature: angiogenesis and tumor metastasis. (1990) (638)
- Regulation of chemotaxis by the platelet-derived growth factor receptor-β (1994) (449)
- Mast cell heparin stimulates migration of capillary endothelial cells in vitro (1980) (421)
- Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD. (1998) (360)
- The cellular basis of site-specific tumor metastasis. (1990) (349)
- In vitro and in vivo consequences of VLA-2 expression on rhabdomyosarcoma cells. (1991) (334)
- Adhesion molecules in tumor metastasis. (1993) (334)
- Inhibition of cell motility by interferon. (1980) (326)
- The c-kit receptor ligand functions as a mast cell chemoattractant. (1992) (321)
- Control of proliferation of human vascular endothelial cells. Characterization of the response of human umbilical vein endothelial cells to fibroblast growth factor, epidermal growth factor, and thrombin (1978) (320)
- The Contribution of Angiogenesis to the Process of Metastasis. (2015) (314)
- Differential endothelial migration and proliferation to basic fibroblast growth factor and vascular endothelial growth factor. (1996) (249)
- Cancer biomarkers: knowing the present and predicting the future. (2005) (240)
- Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro. (1999) (228)
- Inhibition of cell motility after nm23 transfection of human and murine tumor cells. (1993) (225)
- Quantitative Cancer Proteomics: Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC) as a Tool for Prostate Cancer Research*S (2004) (225)
- Migration of capillary endothelial cells is stimulated by tumour-derived factors (1980) (221)
- Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance. (2013) (207)
- Platelet-derived Growth Factor and Fibronectin-stimulated Migration Are Differentially Regulated by the Rac and Extracellular Signal-regulated Kinase Pathways* (1997) (191)
- Platelet-dependent stimulation of prostacyclin synthesis by platelet-derived growth factor (1980) (182)
- Forty-Year Journey of Angiogenesis Translational Research (2011) (178)
- Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment (2015) (159)
- A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumor growth. (1996) (159)
- In vitro characteristics of endothelium from hemangiomas and vascular malformations. (1982) (153)
- Motility and invasion are differentially modulated by Rho family GTPases (2000) (152)
- Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA (2018) (152)
- Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. (1997) (141)
- The Endothelial Cells of Large and Small Blood Vessels (1981) (141)
- Angiogenic activity of adipose tissue. (1988) (139)
- Thymosin β15: A novel regulator of tumor cell motility upregulated in metastatic prostate cancer (1996) (137)
- Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice. (2003) (137)
- Inhibition of endothelial cell migration by thrombospondin-1 type-1 repeats is mediated by β1 integrins (2005) (135)
- Stimulation of human prostatic carcinoma cell growth by factors present in human bone marrow. (1989) (134)
- Antizyme Targets Cyclin D1 for Degradation (2004) (133)
- Stress-inducible, Murine Protein mSTI1 (1997) (130)
- Biomaterials for mRNA delivery. (2015) (128)
- The chemotactic response to PDGF-BB: evidence of a role for Ras (1995) (120)
- Effects of protease treatment on growth, morphology, adhesion, and cell surface proteins of secondary chick embryo fibroblasts (1976) (110)
- Interaction of the Ras-related protein associated with diabetes rad and the putative tumor metastasis suppressor NM23 provides a novel mechanism of GTPase regulation. (1999) (107)
- Cytoskeletal stiffness, friction, and fluidity of cancer cell lines with different metastatic potential (2013) (105)
- miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo (2011) (102)
- Identification of a tumor cell receptor for VGVAPG, an elastin-derived chemotactic peptide (1988) (101)
- Type XXIII Collagen, a New Transmembrane Collagen Identified in Metastatic Tumor Cells* (2003) (100)
- Organ-specific adhesion of metastatic tumor cells in vitro. (1984) (99)
- Self-assembled gold nanoparticle molecular probes for detecting proteolytic activity in vivo. (2010) (94)
- Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells (2010) (93)
- DEF-1/ASAP1 Is a GTPase-activating Protein (GAP) for ARF1 That Enhances Cell Motility through a GAP-dependent Mechanism* (2002) (92)
- Mast cells and angiogenesis. (1992) (92)
- Selective stimulation of prostatic carcinoma cell proliferation by transferrin. (1992) (86)
- Signaling Mechanisms in Growth Factor‐Stimulated Cell Motility (1997) (85)
- Expression of a high molecular weight cell surface glycoprotein (LETS protein) by preimplantation mouse embryos and teratocarcinoma stem cells. (1978) (84)
- Migration of cultured vascular cells in response to plasma and platelet-derived factors. (1982) (82)
- Insulin-Like Growth Factors Promote Vasculogenesis in Embryonic Stem Cells (2012) (77)
- Adjuvant-pulsed mRNA vaccine nanoparticle for immunoprophylactic and therapeutic tumor suppression in mice (2020) (76)
- Urine from patients with transitional-cell carcinoma stimulates migration of capillary endothelial cells. (1981) (72)
- Cystatin B As a Tissue and Urinary Biomarker of Bladder Cancer Recurrence and Disease Progression (2009) (72)
- Regulation of epithelial plasticity by miR-424 and miR-200 in a new prostate cancer metastasis model (2013) (72)
- Isolation of a mouse cDNA encoding MTJ1, a new murine member of the DnaJ family of proteins. (1995) (71)
- Stimulation of mast cell chemotaxis by interleukin 3 (1989) (69)
- Stimulation of rat peritoneal mast cell migration by tumor-derived peptides. (1983) (69)
- Enhanced analysis of metastatic prostate cancer using stable isotopes and high mass accuracy instrumentation. (2006) (68)
- Synthesis and anticancer activity of novel water soluble benzimidazole carbamates. (2018) (68)
- Stimulation of human vascular endothelial cell growth by a platelet-derived growth factor and thrombin. (1979) (68)
- Hybrid lipid-polymer nanoparticles for sustained siRNA delivery and gene silencing. (2014) (66)
- Physical nanoscale conduit-mediated communication between tumour cells and the endothelium modulates endothelial phenotype (2015) (63)
- Regenerative protein thymosin β‐4 is a novel regulator of purinergic signaling (2011) (63)
- Retinal vascular endothelial cells and pericytes. Differential growth characteristics in vitro. (1983) (62)
- Thymosin beta 15: a novel regulator of tumor cell motility upregulated in metastatic prostate cancer. (1996) (60)
- Oxidative stress and thioredoxin-interacting protein promote intravasation of melanoma cells. (2004) (60)
- Tumor vascularity: evaluation in a murine model with contrast-enhanced color Doppler US effect of angiogenesis inhibitors. (2002) (60)
- The nonluteal porcine ovary as a source of angiogenic activity. (1984) (58)
- Identification of an endogenous inhibitor of prostatic carcinoma cell growth (1995) (57)
- Metastatic potential of B16 melanoma cells after in vitro selection for organ-specific adherence (1985) (57)
- The isolation of vascular endothelial cell lines with altered cell surface and platelet-binding properties (1978) (57)
- Corticotropin-releasing hormone stimulates angiogenesis and epithelial tumor growth in the skin. (1999) (56)
- Thrombin potentiates the mitogenic response of cultured fibroblasts to serum and other growth promoting agents (1977) (55)
- Mast cell accumulation at sites of murine tumor implantation: implications for angiogenesis and tumor metastasis. (1994) (53)
- The scientific contributions of M. Judah Folkman to cancer research (2008) (52)
- Multiple ligand binding functions for VLA-2 α2β1 and VLA-3 (α3β1) in the integrin family (1990) (52)
- Membrane-bound protein kinase C modulates receptor affinity and chemotactic responsiveness of Lewis lung carcinoma sublines to an elastin-derived peptide. (1989) (51)
- Binding and internalization of thrombin by normal and transformed chick cells. (1977) (51)
- Adhesive interactions in angiogenesis and metastasis. (1992) (50)
- Human iliac artery endothelial cells express both genes encoding the chains of platelet‐derived growth factor (PDGF) and synthesize PDGF‐like mitogen (1987) (50)
- Isolation of a mouse cDNA encoding mSTI1, a stress-inducible protein containing the TPR motif. (1997) (49)
- Antizyme, a mediator of ubiquitin-independent proteasomal degradation and its inhibitor localize to centrosomes and modulate centriole amplification (2008) (49)
- Identification of genes regulating migration and invasion using a new model of metastatic prostate cancer (2014) (49)
- Angiogenesis. State of the art. (1988) (48)
- Regulation of cell proliferation by the antizyme inhibitor: evidence for an antizyme-independent mechanism (2006) (47)
- Sensitivity to polyamine-induced growth arrest correlates with antizyme induction in prostate carcinoma cells. (1999) (46)
- Cell motility and the extracellular matrix. (1990) (46)
- Evidence of a Role for Antizyme and Antizyme Inhibitor as Regulators of Human Cancer (2011) (46)
- Tumor cell interactions with elastin: implications for pulmonary metastasis. (1989) (45)
- ROLE OF THE HIGH‐MOLECULAR‐WEIGHT GLYCOPROTEIN IN CELLULAR MORPHOLOGY, ADHESION, AND DIFFERENTIATION * (1978) (44)
- Monocyte adhesion to subendothelial components. (1987) (44)
- Gene Therapy of Prostate Cancer with the Soluble Vascular Endothelial Growth Factor Receptor Fk1 (2002) (44)
- Thymosin β15 expression in tumor cell lines with varying metastatic potential (1998) (43)
- Culture of capillary endothelial cells (1984) (38)
- Collagen XXIII Expression Is Associated with Prostate Cancer Recurrence and Distant Metastases (2007) (37)
- C‐terminal variations in β‐thymosin family members specify functional differences in actin‐binding properties (2000) (36)
- The Role of Cell Motility in Prostate Cancer (1998) (36)
- Melanoma cell adhesion to defined extracellular matrix components. (1986) (36)
- LETS Protein in Normal and Pathological Human Oral Epithelium (1979) (35)
- A role for collagen XXIII in cancer cell adhesion, anchorage-independence and metastasis (2012) (35)
- Localization and quantitation of expression of the cell motility-related protein thymosin beta15 in human breast tissue. (1997) (34)
- Lewis lung carcinoma variants with differing metastatic specificities adhere preferentially to different defined extracellular matrix molecules. (1988) (33)
- Functional domains of the insulin receptor responsible for chemotactic signaling. (1994) (33)
- Factors involved in the modulation of cell proliferation in vivo and in vitro: The role of fibroblast and epidermal growth factors in the proliferative response of mammalian cells (2007) (33)
- On target with tumor blood vessel markers (1997) (33)
- Assessing Enzyme Activities Using Stable Isotope Labeling and Mass Spectrometry *S (2007) (32)
- Use of thymosin β15 as a urinary biomarker in human prostate cancer (2005) (30)
- Development of a sensitive and specific enzyme-linked immunosorbent assay for thymosin beta15, a urinary biomarker of human prostate cancer. (2005) (30)
- Collagen XXIII: A Potential Biomarker for the Detection of Primary and Recurrent Non–Small Cell Lung Cancer (2010) (29)
- In situ labelling of vascular endothelium with fluorescent acetylated low density lipoprotein (1985) (28)
- Excess early signaling activity inhibits cellular chemotaxis toward PDGF-BB. (1994) (26)
- [11] Assay of capillary endothelial cell migration (1987) (25)
- Increased stem cell factor release by hemangioma-derived endothelial cells. (1995) (25)
- An in vivo assay for chemoattractant activity. (1985) (24)
- Quantitative proteomics analysis reveals molecular networks regulated by epidermal growth factor receptor level in head and neck cancer. (2010) (23)
- Cell motility in angiogenesis and tumor metastasis. (1990) (22)
- Laminin regulates a tumor cell chemotaxis receptor through the laminin-binding integrin subunit alpha 6. (1993) (19)
- Identification of a transcriptional profile associated with in vitro invasion in non-small cell lung cancer cell lines (2004) (18)
- Proteomics in Tumor Progression and Metastasis (2005) (16)
- Urine From Patients With Transitional-Cell Carcinoma Stimulates Migration of Capillary Endothelial Cells (1982) (16)
- Cancer: The silence of the genes (2002) (16)
- Knockdown of antizyme inhibitor decreases prostate tumor growth in vivo (2012) (16)
- Thymosin β‐NB Is the Human Isoform of Rat Thymosin β15 (2007) (16)
- Multiple ligand binding functions for VLA-2 (alpha 2 beta 1) and VLA-3 (alpha 3 beta 1) in the integrin family. (1990) (15)
- Differential regulation of human thymosin beta 15 isoforms by transforming growth factor beta 1 (2009) (15)
- Cultured endothelial cells derived from the human iliac arteries (1982) (14)
- Assay of capillary endothelial cell migration. (1987) (13)
- Prohibitin 1 regulates tumor cell apoptosis via the interaction with X-linked inhibitor of apoptosis protein. (2016) (13)
- Stimulation of increased capillary endothelial cell motility by chondrosarcoma cell-derived factors. (1983) (13)
- Cell motility in breast cancer. (1996) (12)
- ARE HIGH‐MOLECULAR‐WEIGHT GLYCOPROTEINS REGULATORS OF CELLULAR GROWTH? * (1978) (12)
- Tumor-Cell Interactions with Blood Vessels during Cancer Metastasis (1989) (11)
- Evidence that more deoxynucleotide kinase mRNA is transcribed than translated during T4 infection of Escherichia coli. (1972) (11)
- Hold That Line (2001) (10)
- Use of thymosin beta15 as a urinary biomarker in human prostate cancer. (2005) (9)
- The cellular basis for prostate cancer metastasis. (1992) (9)
- Molecular cloning and structural characterization of the rat thymosin β15 gene (2000) (9)
- Regenerative protein thymosin (cid:1) -4 is a novel regulator of purinergic signaling (2011) (8)
- Shifting Paradigms in Tumor Metastasis: Challenges and Opportunities—A Workshop Report (2002) (8)
- The use of fibroblast and epidermal growth factors to lower the serum requirement for growth of normal diploid cells in early passage: a new method for cloning. (1976) (8)
- Capillary endothelial cell migration: stimulating activity of aqueous humor from patients with ocular cancers. (1983) (8)
- Post-transcriptional regulation of T4 enzyme synthesis. (1974) (8)
- Lipidation Approaches Potentiate Adjuvant-Pulsed Immune Surveillance: A Design Rationale for Cancer Nanovaccine (2020) (8)
- Absence of mast cells in diabetic retinopathy. (1982) (6)
- Ubiquitin-independent degradation and its implication in cancer. (2005) (5)
- Developing a novel FRET assay, targeting the binding between Antizyme-AZIN (2019) (5)
- Author Correction: Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA (2018) (5)
- Molecular cloning and structural characterization of the rat thymosin beta15 gene. (2000) (5)
- The stimulation of capillary endothelial cell migration by aqueous humor. (1981) (4)
- Meeting report: innovations in prostate cancer research. (2008) (4)
- Hold that Line: Angiomotin Regulates Endothelial Cell Motility (2001) (3)
- Abstract 18: Prohibitin 1 regulates apoptosis via its interaction with XIAP (2015) (2)
- Corticotropin releasing hormone is a proangiogenic cytokine (1998) (2)
- Cell Cycle Regulation (2008) (2)
- Restoration of tumor suppression in vivo by systemic delivery of chemically-modified PTEN mRNA nanoparticles. (2017) (2)
- Abstract 4529: Self-assembled lipid-polymer hybrid nanoparticles for the sustained delivery of siRNA and the treatment of drug-resistant cancers. (2013) (2)
- Homing Mechanisms and Cellular Targeting (1994) (2)
- Mitogenic response of cells in tissue culture to thrombin. (1978) (2)
- Prohibitin regulates mTOR pathway via interaction with FKBP8 (2020) (2)
- Abstract 4888: Nuclear localization of antizyme inhibitor may be a marker for aggressiveness of prostate cancer (2019) (2)
- Identification of genes regulating migration and invasion using a new model of metastatic prostate cancer (2014) (2)
- Inhibition of Wnt signaling in colon cancer cells via an oral drug that facilitates TNIK degradation. (2022) (1)
- Elastase production by B16-F10 melanoma cells (1986) (1)
- Inflammation and Cancer: The Role of Lipid Signaling in the Continuum Between Two Ends of the Tumor Spectrum (2017) (1)
- John M. Buchanan (1917–2007) (2007) (1)
- URINE EXPRESSION OF TIMP1, SERPINB1, AND SEMENOGELIN 2 MAY DIFFERENTIATE MEN WITH LOW‐RISK OR NO EVIDENCE OF PROSTATE CANCER FROM MEN WITH HIGH‐RISK OR METASTATIC DISEASE: PD65‐05 (2017) (1)
- CAPILLARY ENDOTHELIAL CELL MIGRATION (2003) (0)
- 887: Proteomic Discovery and Analysis of Cystatin B, A Novel Biomarker in Transitional Cell Carcinoma (2007) (0)
- Abstract 1670: Discovery of novel water-soluble derivatives of mebendazole as selective CLK1/4 kinase inhibitors and their anticancer cancer activity (2018) (0)
- Surviving cancer (2012) (0)
- Cystatin B As aTissue and Urinary Biomarker of Bladder Cancer Recurrence and Disease Progression (2009) (0)
- Author ' s response to reviews Title : Identification of genes regulating migration and invasion using a new model of metastatic prostate cancer (2014) (0)
- Author ' s response to reviews Title : Identification of genes regulating migration and invasion using a new model of metastatic prostate cancer (2014) (0)
- Contents list. (2015) (0)
- Abstract 248: Control of prostate tumor growth and centriole amplification by antizyme and antizyme inhibitor (2011) (0)
- Cystatin BAs aTissue and Urinary Biomarker of Bladder Cancer Recurrence and Disease Progression (2009) (0)
- Method for the prognosis of prostate cancer. (1997) (0)
- Author Correction: Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA (2018) (0)
- Abstract 4565: Antizyme inhibitor regulates the expression of proteins involved in mitosis and affects prostate cancer cell growth (2016) (0)
- Correction (2005) (0)
- Reduced Marcks-related protein expression promotes in vitro cell invasion and tumor desmoplasia (2008) (0)
- Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA (2018) (0)
- Adherence of B16-F10 melanoma cells to elastin (1986) (0)
- Cytoskeletal stiffness, friction, and fluidity of cancer cell lines with different metastatic potential (2012) (0)
- A method for diagnosing prostate cancer (1997) (0)
- Advancing treatment of metastatic cancers: from research to communication--where do we need to go? (2014) (0)
- Abstract 391: Insulin-like Growth Factors Promote Vasculogenesis in Embryonic Stem Cells (2012) (0)
- Abstract LB-311: Characterization of the antizyme/antizyme inhibitor protein-protein interaction using a novel FRET sensor (2017) (0)
- Abstract 4340: Nuclear expression of antizyme inhibitor is associated with poor prostate cancer prognosis (2015) (0)
- Abstract 3854: Antizyme inhibitor editing modulates nuclear localization but not antizyme binding: Implications for prostate cancer (2018) (0)
- Expedition Inspiration Fund for Breast Cancer Research Meeting 2003 (2003) (0)
- Abstract 14: A new orally available drug for the treatment of metastatic cancers (2019) (0)
- Abstract 1231: Restoration of tumor suppressionin vivoby systemic delivery of PTEN mRNA nanoparticles (2017) (0)
- Abstract B46: Collagen XXIII: A biomarker for non‐small cell lung cancer (2009) (0)
- Nouvelles compositions biotinylatees (2006) (0)
- Abstract 3600: NanoChannel-mediated communication between tumor cells and endothelium mediates metastatic parasitism (2014) (0)
- Diagnosis and prognosis methods of bladder cancer. (2006) (0)
- Interleukin 3 (2020) (0)
- Advances in Brief Sensitivity to Polyamine-induced Growth Arrest Correlates with Antizyme Induction in Prostate Carcinoma Cells (1999) (0)
- Cellular Models for Angiogenesis Research (1994) (0)
- Abstract 2032: MicroRNA control of tumor cell plasticity in a new tumor metastasis model (2010) (0)
- Knockdown of antizyme inhibitor decreases prostate tumor growth in vivo (2011) (0)
- Abstract 2896: Nanoparticle co-delivery of RNAi and chemotherapy for the treatment of drug-resistant cancers (2012) (0)
- Gene of human thymosin beta 15, protein and uses thereof. (1997) (0)
- Vitamin D Binding Protein-Macrophage Activating Factor ( DBP-maf ) Inhibits Angiogenesis and Tumor Growth in Mice 1 (2002) (0)
- Course Announcement (2004) (0)
- Reviewers of the Journal of Chemotherapy (2010) (0)
- Murine Tumor Cells Transfection of Human and nm 23 Inhibition of Cell Motility after Updated (2006) (0)
- Collagen XXIII- a biomarker for lung adenocarcinoma (2008) (0)
- Unbiased Phenotype-Based Screen Identifies Therapeutic Agents Selective for Metastatic Prostate Cancer (2021) (0)
- How It Came to Pass That Interferon Was Used as an Angiogenesis Inhibitor (2009) (0)
- Abstract 508: A novel orally available Wnt-pathway inhibitor for the treatment of metastatic cancers (2020) (0)
- Abstract 1822: RNA eding of AZIN1 increases cellular aggressiveness in prostate cancer (2020) (0)
- A New Marker for the Detection of Transitional Cell Carcinoma (1983) (0)
- Potential Prognostic Markers for Human Prostate Cancer (2001) (0)
- Course Announcement (2004) (0)
- Abstract 1551: Benzimidazole as novel therapeutic agent for metastatic prostate cancer (2010) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Bruce R. Zetter?
Bruce R. Zetter is affiliated with the following schools:
